Replies to post #44301 on Biotech Values

[DewDiligence]

>There is other treatment option. It is the already FDA approved drug Erbitux.<

I interpreted the quoted passage you cited to mean that only Vectibix was tested in patients refractory to irinotecan and oxaliplatin. If that’s not what was meant, then the passage makes no sense.